OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTION 240.24b-2 LICENSE, CO- DEVELOPMENT AND COMMERCIALIZATION AGREEMENT between Palatin Technologies, Inc. and Chemical Works...Development and Commercialization Agreement • September 12th, 2014 • Palatin Technologies Inc • Pharmaceutical preparations
